Use of DNA haplotype analysis in diagnosis of familial hypercholesterolaemia in 31 German families.
Open Access
- 1 December 1991
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 28 (12) , 865-870
- https://doi.org/10.1136/jmg.28.12.865
Abstract
In the majority of patients, familial hypercholesterolaemia (FH) is caused by different mutations affecting the well defined low density lipoprotein receptor (LDLR) gene. However, 3% of patients in Munich with a clinical diagnosis of FH have a particular mutation in the apolipoprotein B gene causing familial defective apolipoprotein B-100 (FDB). To date none of the LDLR mutations causing FH in German patients has been identified and it is therefore not yet possible to use DNA technology for direct diagnosis. However, indirect molecular diagnosis based on genetic linkage of common restriction fragment length polymorphisms (RFLPs) of the LDLR gene can be used for diagnosis in family studies. Patients with FDB were excluded from this study. Genotypes and haplotypes of four RFLPs (StuI, ApalI 5', PvuII, and NcoI) were determined in a total of 164 independent alleles from 31 pedigrees that included 222 subjects. Allele frequencies and four RFLP haplotype distribution did not differ significantly from those reported in other populations. The applicability of DNA diagnosis in our lipid clinic is comparable with the estimation from calculations on frequencies and heterozygosities of RFLPs, as predicted using these four RFLPs before. On the basis of cosegregation of haplotypes and normo- or hypercholesterolaemia in one or more sibs or offspring, defective and normal LDLR gene alleles could be distinguished in 42 of 58 heterozygous FH patients who were heterozygous for at least one RFLP. In 97 of 134 (72%) children of these 42 subjects, diagnosis of FH could be carried out unambiguously.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 22 references indexed in Scilit:
- Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.Journal of Clinical Investigation, 1989
- Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype.Journal of Clinical Investigation, 1989
- Haplotypes identified by 10 DNA restriction fragment length polymorphisms at the human low density lipoprotein receptor gene locus.Journal of Medical Genetics, 1989
- Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus.Journal of Medical Genetics, 1988
- Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions.Journal of Clinical Investigation, 1988
- Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial HypercholesterolemiaNew England Journal of Medicine, 1987
- The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupt transport and processing of a membrane receptorCell, 1983
- Serum cholesterol levels in patients with familial hypercholesterolemia confirmed by tissue cultureAtherosclerosis, 1981
- Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol.BMJ, 1977